Oral Semaglutide: CU Anschutz Trial Reveals Potential for Fewer Heavy Drinking Days
A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder